| 12 | Purchase Agreement 24 pages Follow this link to | Markss40 | 03/10/2020 9:10:23 AM |
| 11 | STNT Financials 07/15/2014 22:58:00 Stevia Nutra | Emylers | 07/15/2014 11:57:58 PM |
| 10 | Latest Stevia Nutra Corp (STNT) Headlines Stevia | Stock_Tracker | 03/11/2014 1:46:29 PM |
| 9 | STNT 0.0119 Stock Charts $STNT 1 Month Chart | chartguy89 | 03/10/2014 1:42:53 AM |
| 8 | STNT Stock Charts Last: +0.002 Saturday, March 1, | chartguy89 | 03/01/2014 8:16:02 PM |
| 7 | $STNT Natural sweetener coming | Alex_Ambition | 05/29/2012 9:03:16 AM |
| 6 | this might be a different Stevia Stock as far as | Alex_Ambition | 05/28/2012 12:12:52 AM |
| 5 | I made some money in this a while back, been | equijohn | 05/27/2012 7:41:14 PM |
| 4 | 76,500,000 common shares issued and | Alex_Ambition | 05/27/2012 1:14:01 PM |
| 3 | $1.6 Million traded between .81 ~ .95 range with | Alex_Ambition | 05/27/2012 1:07:51 PM |
| 2 | Stevia Nutra Corp Establishes Major Cambodian | Alex_Ambition | 05/27/2012 1:49:40 AM |
| 1 | Took a position here on Thursday .... hoping it | Alex_Ambition | 05/27/2012 12:36:05 AM |
Recent Articles
- Investigation into Avidity Biosciences' Sale to Novartis
- POET Technologies Secures $150 Million in Investment for Growth
- Perseus Mining Reports Strong Operational Results for Q3 2025
- Secure Your Rights: Quantum Corporation Investors Must Act Now
- Investors Urged to Act Ahead of Semler Scientific Class Action
- Cygnus Metals Welcomes New CEO to Spearhead Future Growth
- Cygnus Announces Leadership Changes with New CEO Appointment
- Nyrstar NV Faces Appeal Following FSMA Sanctions Committee Ruling
- MapLight Therapeutics: Pioneering Solutions for CNS Disorders
- MapLight Therapeutics Sets Price for Its Highly Anticipated IPO
- Stay Informed: Key Legal Updates for Dow Inc. Investors
- Medtronic's Innovative Blood Pressure Treatments Show Long-Term Success
- Tronox Holdings PLC Investors Urged to Act Before Deadline
- CAPHRA's Asia Day: A Vital Approach to Tobacco Harm Reduction
- Influential Tech Leaders Shape Policy Decisions on Troops
- Transformative Financial Insights from Warren Buffett for the Elite
- Corporate Giants Fuel Trump's $300 Million Ballroom Dream
- Apple Inc. Enhances iPad Pro with Vapor Chamber Technology
- LifeMD, Inc.: Investors Encouraged to Claim Their Rights
- Breaking News: Louvre Heist Culprits Arrested in France
- Anthony Scaramucci Voices Support for Changpeng Zhao's Pardon
- General Motors Ditches CarPlay: A Shift Towards Innovation
- Exploring Trump's Bold Strategy of Gold for Bitcoin Exchange
- Cristcot Showcases Promising UC Treatment Data at Annual Meeting
- Innovative TissueCypher Test Enhances Management of Barrett's Esophagus
- Seniors Express Concerns as Social Security Payments Increase
- Castle Biosciences Unveils Key Data on TissueCypher at ACG
- Cordis Announces Innovative Results from Groundbreaking Trials
- Shaquille O'Neal's Luxury SUV Stolen in Cyber Heist
- Marex Group plc Securities Class Action Update and Guidance
- How the Fed's Balance Shift Could Impact Bitcoin Prices
- ARETI International Group Sponsors Mayflower Gran Prix 2025
- Big Week for Stocks: Major Gainers and Surprising Trends
- Microsoft's Strategic Shift in AI Development and Ethics
- U.S.-China Trade Agreement: Impact on Economy and Relations
- Recent Trends in Large Cap Stocks: Key Market Movers
- Avidity Biosciences Announces Acquisition by Novartis AG Deal
- Legal Action Encouraged for Designer Brands Inc. Investors
- Exploring the Future of Kratom: Insights from Kratom Bird
- Novartis Enhances Neuroscience Pipeline Through Avidity Biosciences Acquisition
- EggNest™ System: A Breakthrough in Radiation Safety for Cath Labs
- Critical Importance of Court Reporting in High-Profile Trials
- Mark Cuban's Insight: Billionaires and Market Stability
- Blockchain Jungle 2025: Experience Innovation in Technology
- Fortinet Shareholders Urged to Join Securities Class Action
- Controversial $130 Million Donation to Pentagon Raises Concerns
- Fate Therapeutics: Advances in CAR T-Cell Therapy for Lupus
- JPMorgan Faces Legal Challenge Over Excessive Fraud Fees
- JPMorgan Fights $115 Million Legal Fees After Fraud Case
- Fate Therapeutics Unveils Promising Data on FT819 CAR T-Cell Therapy
